Europe Pharmaceutical Continuous Manufacturing Market is expected to reach US$ 799.50 Mn by 2027

The integrated systems Segment to Grow at Faster Pace During Forecast Period

According to a new market research study of “Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Product, Application and End User,” the Europe pharmaceutical continuous manufacturing market is projected to reach US$ 799.50 million by 2027 from US$ 374.95 million in 2019. The market is estimated to grow at CAGR of 10.0% from 2020 to 2027. The report highlights trends prevailing in the Europe pharmaceutical continuous manufacturing market and the factors driving market along with those that act as hindrances.

The Europe pharmaceutical continuous manufacturing market, based on product, is further segmented into integrated systems, semi-continuous systems, and controls. The integrated systems segment held a larger share of the market in 2019 and, also the similar segment is estimated to register a higher CAGR during the forecast period. The system helps to complete a continuous manufacturing for R&D, which gives more possibility to understand the continuous manufacturing technology to achieve consequently, which is likely to drive the growth for pharmaceutical continuous manufacturing market during the forecast period.

The Europe pharmaceutical continuous manufacturing market is expected to grow owing to increasing shortage of medicines in the region. However, high cost involved in drug manufacturing is likely to restrain the growth of the market during the forecast period.

Europe has been massively hit by the COVID-19 outbreak affecting many of its countries on a large scale. Italy, Germany, Spain, UK, and France, along with other European countries, are continually witnessing a rise in several coronavirus cases every day. Europe is facing a massive impact on an outbreak due to the exponential growth of infections in the region. As per data published by public sources, till March 26, Europe had an estimated 250,000 number of infected patients in the region. Also, the process of shutting down is expected to have a severe impact on new product launches and distributions. For instance, Comecer is headquartered in Italy with its factories in Italy and the Netherlands due to the lockdown and severe spread of coronavirus, and complete lockdown in the country will affect the manufacturing process of continuous pharmaceutical manufacturing.

Leading companies operating in the pharmaceutical continuous manufacturing market are Fette Compacting, KORSCH AG, LEISTRITZ AG, ALEXANDERWERK AG, Hovione and, among others.

Europe Pharmaceutical Continuous Manufacturing Market, By Country, 2019 (%)

The report segments Europe Pharmaceutical Continuous Manufacturing Market as follows:

By Product

• Integrated Systems
• Semi-Continuous Systems
  • Continuous Granulators
  • Continuous Blenders
  • Continuous Compressors

  • Continuous Coaters
  • Continuous Dryers
  • Other Semi-Continuous Systems
• Controls

By Application

• End Product Manufacturing
  • Solid Dosage Manufacturing
  • Liquid Dosage Manufacturing
• API Manufacturing

By End-User

• Full Scale Manufacturing Companies
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
• R & D Departments
  • Contract Research Organizations
  • Research Institutes

By Country

• UK
• Germany
• France
• Italy
• Spain